RM

RP Management Portfolio holdings

AUM $139M
This Quarter Return
+22.62%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$201M
AUM Growth
+$201M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$154M 72.03%
1,111,111
– –
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$46.9M 21.9%
9,166,667
– –
VIRX
3
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$30K 0.01%
3,700
– –